Serotonin and Noradrenaline Reuptake Inhibitors
"Serotonin and Noradrenaline Reuptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.
| Descriptor ID |
D000068760
|
| MeSH Number(s) |
D27.505.519.562.437.693 D27.505.519.625.600.693 D27.505.696.577.600.693
|
| Concept/Terms |
Serotonin and Noradrenaline Reuptake Inhibitors- Serotonin and Noradrenaline Reuptake Inhibitors
- SSRIs and NRIs
- NRIs and SSRIs
- Serotonin and Noradrenaline Uptake Inhibitors
- SNRIs
- Serotonin and Norepinephrine Reuptake Inhibitors
- Serotonin and Norepinephrine Uptake Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Serotonin and Noradrenaline Reuptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Serotonin and Noradrenaline Reuptake Inhibitors".
This graph shows the total number of publications written about "Serotonin and Noradrenaline Reuptake Inhibitors" by people in this website by year, and whether "Serotonin and Noradrenaline Reuptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Serotonin and Noradrenaline Reuptake Inhibitors" by people in Profiles.
-
Antidepressants Reduced Risk of Mortality in Patients With Diabetes Mellitus: A Population-Based Cohort Study in Taiwan. J Clin Endocrinol Metab. 2019 10 01; 104(10):4619-4625.
-
Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study. Curr Med Res Opin. 2019 12; 35(12):2169-2177.
-
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults. J Am Geriatr Soc. 2019 08; 67(8):1571-1581.
-
Takotsubo cardiomyopathy associated with serotonin syndrome in a patient with stroke: A case report. Medicine (Baltimore). 2019 Mar; 98(13):e15057.
-
Analysis of the Effects of Selective Serotonin (and Noradrenaline) Reuptake Inhibitors on the Risk of Dementia in Patients with Depression. J Alzheimers Dis. 2019; 69(2):577-583.
-
Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients. Anesth Analg. 2018 06; 126(6):1859-1866.
-
A Naturalistic Evaluation of Change in Antidepressant Prescription in Patients With Affective and Anxiety Disorders in a Tertiary Care Hospital of India. J Clin Psychopharmacol. 2018 Feb; 38(1):47-50.
-
Efficacy of levomilnacipran extended release in treating major depressive disorder. Expert Opin Pharmacother. 2017 Dec; 18(18):2017-2024.
-
Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm. Crit Care Med. 2017 Jun; 45(6):e607-e616.
-
Bone Turnover with Venlafaxine Treatment in Older Adults with Depression. J Am Geriatr Soc. 2017 Sep; 65(9):2057-2063.